|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 346.80 CHF | -0.60% |
|
+1.26% | +5.67% |
| 01-18 | Bayer Receives EU Approval for High-Dose Eylea in Another Indication | DP |
| 01-16 | Goldman Sachs Upgrades Roche to Neutral, Boosts PT | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCHE HOLDING AG | Other Pharmaceuticals | -0.60% | +1.26% | +5.67% | +29.94% | +8.99% | 371B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ROG Stock
- Charts Roche Holding AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition